Trial intelligence / Profile preview

JT001 (VV116) for early treatment of mild to moderate COVID-19

PACTR202210559228718Phase 3Not yet recruiting

Sponsor

Shanghai Junshi Biosciences Co., Ltd.

Start

Oct 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1